Cargando…
Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers
BACKGROUND: Lung cancers account for the majority of brain metastases which pose major therapeutic challenges. Biomarkers prognosticating for the development of brain metastases in patients with non-small cell lung cancers (NSCLC) may improve personalized care. Six serum proteomic biomarkers were pr...
Autores principales: | Li, Bob T., Lou, Emil, Hsu, Meier, Yu, Helena A., Naidoo, Jarushka, Zauderer, Marjorie G., Sima, Camelia, Johnson, Melissa L., Daras, Mariza, DeAngelis, Lisa M., Fleisher, Martin, Kris, Mark G., Azzoli, Christopher G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4701719/ https://www.ncbi.nlm.nih.gov/pubmed/26730601 http://dx.doi.org/10.1371/journal.pone.0146063 |
Ejemplares similares
-
The therapeutic implications of the genomic analysis of malignant pleural mesothelioma
por: Zauderer, Marjorie G.
Publicado: (2021) -
12. OUTCOMES AFTER SURGICAL RESECTION OF MELANOMA BRAIN METASTASES IN THE AGE OF CHECKPOINT INHIBITOR TREATMENT
por: Morshed, Ramin, et al.
Publicado: (2020) -
Molecular Interactions in the Development of Brain Metastases
por: Martinez, Nina, et al.
Publicado: (2013) -
Dynamic contrast‐enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases
por: Hatzoglou, Vaios, et al.
Publicado: (2017) -
Some like it hot: the potential role of hyperthermic intrathoracic chemotherapy in the multimodality treatment of pleural mesothelioma
por: Branch, Kevin, et al.
Publicado: (2023)